Loncar Cancer Immunotherapy ETF’s (CNCR) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Loncar Cancer Immunotherapy ETF is a Sell.
Loncar Cancer Immunotherapy ETF’s (CNCR) 20-Day exponential moving average is 15.15, making it a Buy.
Loncar Cancer Immunotherapy ETF’s (CNCR) 50-Day exponential moving average is 15.01, making it a Buy.